What Is Semax?
Semax is a short peptide studied in cognitive research supplied by Peptegrity for research and educational purposes. This page provides a factual educational overview of Semax, including its classification, biological target, research background, terminology and published study context. It is not a product page and does not provide dosing instructions, treatment recommendations or personal-use guidance.
Type of compound
Semax is a synthetic heptapeptide analogue of the adrenocorticotropic hormone (ACTH) fragment 4-10. It is primarily categorized in scientific literature as a nootropic peptide under investigation for its neurological effects.
Biological target and mechanism
Research indicates that Semax interacts with brain-derived neurotrophic factor (BDNF) and its receptor, TrkB, in the hippocampus and basal forebrain [1, 2]. Furthermore, studies suggest it may modulate the dopaminergic and serotonergic systems [4] and influence the expression of vascular endothelial growth factor (VEGF) family genes [3].
Research background
Scientific interest in Semax stems from its structural similarity to endogenous ACTH fragments, which are known to play roles in modulation of the central nervous system. Investigators have explored the compound's potential to influence neuroprotective pathways and cognitive processes in rodent models [1, 4].
Current research and development status
Semax is an investigational compound currently utilized exclusively for scientific research in laboratory and preclinical settings. It has not been approved by the FDA or the TGA for any human therapeutic or clinical use.
Published research context
Published studies on Semax have focused on its potential to elevate BDNF protein levels [1, 2] and its role in gene expression during focal ischemia models [3]. Additionally, research has examined the impact of different administrative routes on its observed effects in rodent models [5].
Relevant terminology
A nootropic is a substance investigated for its potential to affect cognitive functions. In this context, it refers specifically to the study of synthetic peptides designed to interact with neurobiological pathways associated with learning and memory.
Storage and handling terminology
Research peptides are typically stored as lyophilized powders in a controlled, refrigerated environment to maintain molecular stability. Proper handling protocols involve dissolving the compound in a sterile solvent only at the time of intended experimental use to prevent degradation.
Testing and Certificate of Analysis (COA)
A Certificate of Analysis (COA) is a document provided by a laboratory to certify that a chemical batch has been tested for purity and identity. Researchers should verify that a COA includes data from high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to confirm the compound's purity profile.
Regulatory status
Semax is strictly for research and development purposes only. It is not approved by major regulatory bodies for human consumption, clinical treatment, or diagnostic applications.
This page is for research and educational purposes only. It is not intended to provide medical advice, dosing instructions, or treatment recommendations, and does not represent any product as approved to diagnose, treat, cure or prevent any disease. Compounds described here may be investigational or unapproved medicines; regulatory status is summarised for information only.
Frequently asked questions
What is Semax?
Semax is a synthetic peptide analogue derived from the ACTH 4-10 sequence, frequently used as a tool in neurobiological research.
How is Semax classified in scientific studies?
It is classified as a synthetic heptapeptide and is categorized in research as a nootropic agent being investigated for its neurochemical interactions.
What is the regulatory status of Semax?
Semax is considered an investigational research chemical and has not been approved for clinical use or human consumption by regulatory authorities.
What biological systems does Semax interact with in research?
Laboratory research has observed that Semax may influence BDNF protein levels, VEGF gene expression, and dopaminergic or serotonergic pathways [1, 3, 4].
Can Semax be used for personal health or clinical treatment?
No, Semax is not a medicine and is restricted to in vitro or in vivo laboratory research settings only.
References
- 1.Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrainPubMed
- 2.Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampusPubMed
- 3.Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of the VEGF gene family in the rat brain during focal ischemiaPubMed
- 4.Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodentsPubMed
- 5.Nootropic and analgesic effects of Semax following different routes of administrationPubMed
